Have a personal or library account? Click to login
Thin layer chromatographic compatibility study in preformulation of new transdermal therapeutic systems Cover

Thin layer chromatographic compatibility study in preformulation of new transdermal therapeutic systems

Open Access
|Mar 2020

References

  1. 1. Srinivasarao K, Sai Adithya B, Teja D, Manikiran S, Ramarao N, An Overview on Preformulation for Pharmaceutical Product Development and Drug Excipient Incompatibility Studies. International Journal of Pharma and Chemical Research. 2017;3:354-368.
  2. 2. Vizserálek G, Berkó S, Tóth G, Balogh R, Budai-Szűcs M, Csányi E, et al. Permeability Test for Transdermal and Local Therapeutic Patches Using Skin PAMPA Method. Eur J Pharm Sci. 2015; 30:165-172.10.1016/j.ejps.2015.05.00425957747
  3. 3. Paudel KS, Milewski M, Swadley CL, Brogden NK, Ghosh P, Stinchcomb AL. Challenges and opportunities in dermal/transdermal delivery. Ther Deliv. 2010;1:109-131.10.4155/tde.10.16299553021132122
  4. 4. Feneran AN, Kaufman WS, Dabade TS, Feldman SR. Retinoid plus antimicrobial combination treatments for acne. Clin Cosmet Investig Dermatol. 2011;4:79-92.
  5. 5. Kobayashi M, Nakagawa T, Fukamachi K, Nakamura M, Tokura Y. Efficacy of combined topical treatment of acne vulgaris with adapalene and nadifloxacin: a randomized study. J Dermatol. 2011;38:1163-1166.10.1111/j.1346-8138.2011.01280.x22007904
  6. 6. Takigawa M, Tokura Y, Shimada S, Furukawa F, Noguchi N, Ito T. Acne Study Group. Clinical and bacteriological evaluation of adapalene 0.1% gel plus nadifloxacin 1% cream versus adapalene 0.1% gel in patients with acne vulgaris. J Dermatol. 2013;40:620-625.10.1111/1346-8138.1218923724808
  7. 7. Kawada A, Wada T, Oiso N. Clinical effectiveness of once-daily levofloxacin for inflammatory acne with high concentrations in the lesions. J Dermatol. 2012;39:94-96.10.1111/j.1346-8138.2011.01216.x21545499
  8. 8. Prajapati SK, Kumar S, Singh A, Singh A. Development and characterization of topical microemulsion of levofloxacin, World J Pharm Pharm Sci. 2013;2:5935-5947.
  9. 9. Jakeer Hassan SK, Meena T, Lakshmi Durga T, Shahanaj SK. Formulation and evaluation of levofloxacin ointment. International Journal of Pharmaceutical Sciences and Research. 2015;6:3067-3075.
  10. 10. Shtanyuk YA. Analysis of antibacterial activity of ointments with levofloxacin and decametoxine on clinical strains agents of wound infections. World of Medicine and Biology. 2015;52:74-77.
  11. 11. Mesquita-Guimaraes J, Ramos S, Tavares MR, Carvalho MR. A double-blind clinical trial with a lotion containing 5% benzoyl peroxide and 2% miconazole in patients with acne vulgaris. Clin Exp Dermatol. 1989;14:357-360.10.1111/j.1365-2230.1989.tb02584.x2532986
  12. 12. Flagothier C, Vroome V, Borgers M, Wang X, Cauwenbergh G, Piérard GE. Effect of a single overnight topical application of miconazole nitrate paste on acne papules. Int J Dermatol. 2006;45:316-319.10.1111/j.1365-4632.2006.02685.x16533239
  13. 13. Fatemi F, Najafian J, Nasab SS, Nilforoushzadeh MA. Treatment of Acne Vulgaris Using the Combination of Topical Erythromycin and Miconazole, Skin Stem Cell. 2014;1:e23330.10.17795/jssc23330
  14. 14. Hori S, Kizu J, Kawamura M. Effects of anti-inflammatory drugs on convulsant activity of quinolones: a comparative study of drug interaction between quinolones and anti-inflammatory drugs. J Infect Chemother. 2003;9:314-320.10.1007/s10156-003-0275-114691652
  15. 15. Dumka VK, Singh H, Srivastava AK. Disposition kinetics and urinary excretion of levofloxacin on concomitant administration with meloxicam in cross-bred calves. Environ Toxicol Pharmacol. 2008;26:56-60.10.1016/j.etap.2008.01.00721783888
  16. 16. Khan AM, Rampal S, Sood NK. Effect of repeated oral administration of levofloxacin, enrofloxacin, and meloxicam on antioxidant parameters and lipid peroxidation in rabbits. Hum Exp Toxicol. 2017;36:42-50.10.1177/0960327116637111
  17. 17. Meyyanathan SN, Ramasarma GVS, Suresh B. Analysis of Levofloxacin in Pharmaceutical Preparations by High Performance Thin Layer Chromatography. J Sep Sci. 2003;26:1698-1700.10.1002/jssc.200301616
  18. 18. Agrawal OD, Shirkhedkar AA, and Surana S.J. Simultaneous Determination of Levofloxacin Hemihydrate and Ambroxol Hydrochloride in Tablets by Thin-Layer Chromatography Combined with Densitometry. J Anal Chem. 2010;65:418-422.10.1134/S1061934810040131
  19. 19. Rusu A. Merdar M. Hancu G. Gyéresi Á. Thin-layer chromatographic study regarding the separation of some quinolone derivatives. Medicine in evolution. 2011;XVII:61-65.
  20. 20. Hopkała H, Pomykalski A. TLC Analysis of Inhibitors of Cyclooxygenase and Videodensitometric Determination of Meloxicam and Tiaprofenic Acid. JPC. 2003;16:107-111.10.1556/JPC.16.2003.2.4
  21. 21. Shaji, J, Varkey D. Development of a validated stability-indicating HPTLC method for determination of meloxicam in bulk and pharmaceutical formulations: pertinence to ICH guidelines. Int J Pharm Pharm Sci. 2012;4:160-169.
  22. 22. Starek M, Krzek J. TLC Determination of Meloxicam in Tablets and after Acidic and Alkaline Hydrolysis. Acta Pol Pharm. 2012;69:225-235.
  23. 23. Indrayanto G, Widjaja S, Sutiono S. Simultaneous Densitometric Determination of Betamethasone Valerate and Miconazole Nitrate in Cream, and Its Validation. 1999;22:143-152.
  24. 24. Council of Europe, European Pharmacopoeia 9.7, 9th Edition, Council of Europe, Strasbourg, 2018, 6643
  25. 25. Wall PE, Thin-layer Chromatography, A Modern Practical Approach, RSC Chromatography Monographs, Cambridge UK, 2005, 86-100
  26. 26. Bhatia G, Zhou Y, Banga AK. Adapalene microemulsion for transfollicular drug delivery. J Pharm Sci. 2013;102:2622-2631.10.1002/jps.23627
  27. 27. Shroot B., Michel S. Pharmacology and Chemistry of Adapalene. J Am Acad Dermatol. 1997;36:S96-103.10.1016/S0190-9622(97)70050-1
  28. 28. Modi PB, Shah NJ. Novel Stability-Indicating RP-HPLC Method for the Simultaneous Estimation of Clindamycin Phosphate and Adapalene along with Preservatives in Topical Gel Formulations. Sci Pharm. 2014;82:799–813.10.3797/scipharm.1404-01447580626171325
  29. 29. Roy C, Panigrahi L, Chakrabarty J. Validated Stability-Indicating RP-HPLC Method for the Estimation of Degradation Behaviour of Organic Peroxide and Third-Generation Synthetic Retinoids in Topical Pharmaceutical Dosage Formulation. Sci Pharm. 2015;83:321–338.10.3797/scipharm.1412-10472780026839821
  30. 30. Chadha R, Bhandari S. Drug-excipient compatibility screening-role of thermoanalytical and spectroscopic techniques. J Pharm Biomed Anal. 2014;87:82-97.10.1016/j.jpba.2013.06.01623845418
DOI: https://doi.org/10.2478/amma-2020-0004 | Journal eISSN: 2668-7763 | Journal ISSN: 2668-7755
Language: English
Page range: 23 - 29
Submitted on: Jul 5, 2019
Accepted on: Jan 13, 2020
Published on: Mar 31, 2020
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 Octavia-Laura Moldovan, Diana-Nicoleta Brihan, Nicoleta Todoran, Aura Rusu, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.